These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3051595)

  • 1. Pre-transplant transfusions in renal recipients treated with cyclosporine: a subject of controversy.
    Ortuño J; Pelaez E; Teruel JL; Orte L; Marcén R; Felipe C; Matesanz R; Quereda C
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):70-2. PubMed ID: 3051595
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract]   [Full Text] [Related]  

  • 3. The transfusion effect.
    Tokunaga K; Terasaki PI
    Clin Transpl; 1986; ():175-88. PubMed ID: 3154399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract]   [Full Text] [Related]  

  • 6. The transfusion effect.
    Cecka JM
    Clin Transpl; 1987; ():287-301. PubMed ID: 3154420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
    Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
    Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract]   [Full Text] [Related]  

  • 9. Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine.
    Cristinelli L; Brunori G; Setti G; Manganoni A; Manganoni AM; Scolari F; Sandrini S; Scaini PS; Savoldi S; Camerini C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2021-3. PubMed ID: 3079069
    [No Abstract]   [Full Text] [Related]  

  • 10. Early and late complications of cyclosporine treatment in a 5-year follow-up of 250 renal transplant recipients.
    Civati G; Busnach G; Perrino ML; Broggi ML; Brando B; Seveso M; Minetti L
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1571-2. PubMed ID: 2652510
    [No Abstract]   [Full Text] [Related]  

  • 11. There is no need to give blood transfusions as pretreatment for renal transplantation in the cyclosporine era.
    Groth CG
    Transplant Proc; 1987 Feb; 19(1 Pt 1):153-4. PubMed ID: 3079151
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study.
    Chavers BM; Sullivan EK; Tejani A; Harmon WE
    Pediatr Transplant; 1997 Aug; 1(1):22-8. PubMed ID: 10084783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing cadaver kidney transplantation outcome in the cyclosporine era. The North Italy Transplant Program (NITp).
    Clin Transpl; 1988; ():131-45. PubMed ID: 3154466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No difference in outcome between 314 nontransfused and 614 transfused cadaveric renal transplant recipients: the Scandinavian experience.
    Lundgren G; Groth CG; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gugerli U; Gäbel H; Lindholm A; Persson H
    Clin Transpl; 1987; ():249-55. PubMed ID: 3154412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transfusion effect.
    Iwaki Y; Cecka JM; Terasaki PI
    Clin Transpl; 1988; ():283-92. PubMed ID: 3154480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphokine production in cyclosporine-treated renal transplant recipients.
    McKenna RM; Rush DN; Bakkestad-Legare P; Jeffrey JR
    Transplant Proc; 1988 Dec; 20(6):1245-7. PubMed ID: 3144073
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine improves outcome in high-risk cadaveric renal allograft recipients.
    Van Buren CT; Flechner SM; Kerman RH; Vaughn W; Kahan BD
    Transplant Proc; 1984 Oct; 16(5):1162-6. PubMed ID: 6385365
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of transfusions on renal allograft survival in the cyclosporine era: a single center report.
    Egidi MF; Scott DH; Corry RJ
    Clin Transplant; 1993 Jun; 7(3):240-4. PubMed ID: 10148843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.